2024 American Academy of Neurology Abstract Website

Disclosures for "Seizures in the Leukodystrophies"

Dr. Hackett has nothing to disclose.
Miss Liu has nothing to disclose.
Ms. Yan has nothing to disclose.
Dr. Corre has nothing to disclose.
Miss Gao has nothing to disclose.
Mr. Kelly has nothing to disclose.
Ms. Ghabash has nothing to disclose.
Mr. Goodman has nothing to disclose.
Dr. Benko has stock in Orchard. Dr. Benko has received personal compensation in the range of $500-$4,999 for serving as a Expert- Surveys with Connected Research .
Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC.
Dr. Fatemi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for RCO law. The institution of Dr. Fatemi has received research support from Minoryx. The institution of Dr. Fatemi has received research support from Viking Therapeutics. The institution of Dr. Fatemi has received research support from Swanbio Therapeutics . The institution of Dr. Fatemi has received research support from Autobahn Therapeutics. The institution of Dr. Fatemi has received research support from Nuvelution. The institution of Dr. Fatemi has received research support from NIH. The institution of Dr. Fatemi has received research support from A Cure for Ellie Foundation. The institution of Dr. Fatemi has received research support from Brian's Hope Foundation . Dr. Fatemi has received intellectual property interests from a discovery or technology relating to health care. Dr. Fatemi has a non-compensated relationship as a Director (Board member) with ALDConnect that is relevant to AAN interests or activities.
Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Dr. Keller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veristat, LLC. Dr. Keller has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for United Leukodystrophy Foundation. The institution of Dr. Keller has received research support from CHOP/NIH. The institution of Dr. Keller has received research support from IONIS. The institution of Dr. Keller has received research support from Biomarin. Dr. Keller has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Federal Food and Drug Administration Cellular, Tissue, and Gene Therapies Advisory Committee.
An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
Maria Escolar has received personal compensation for serving as an employee of Forge Biologics. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Azafaros. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for JCR. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BridgeBio. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEGA Therapeutics. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphazyme. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shire/Takeda. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeglea Bio. Maria Escolar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Shire/Takeda. Maria Escolar has received stock or an ownership interest from Forge Biologics. The institution of an immediate family member of Maria Escolar has received research support from The Legacy of Angels. The institution of an immediate family member of Maria Escolar has received research support from NIH. The institution of Maria Escolar has received research support from The Legacy of Angels. Maria Escolar has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Maria Escolar has received intellectual property interests from a discovery or technology relating to health care.
Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
The institution of Dr. Mallack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Science. The institution of Dr. Mallack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lysogene. Dr. Mallack has received research support from NINDS.